Ruling Party, Government, and Cheong Wa Dae Agree to Maintain Health Research Institute and Disease Control Headquarters as Subordinate Agencies

[Asia Economy Reporter Jeon Jin-young] The Democratic Party of Korea, the government, and the Blue House have decided to elevate the Korea Centers for Disease Control and Prevention to the Korea Disease Control and Prevention Agency and to maintain the National Institute of Health as an agency under the Korea Disease Control and Prevention Agency.

Kim Tae-nyeon, floor leader of the Democratic Party of Korea, is delivering opening remarks at the 'Disease Control Agency Reorganization Plan Party-Government Consultation' held at the National Assembly on the 15th. Photo by Yoon Dong-joo doso7@

On the morning of the same day, the party, government, and Blue House held a 'Party-Government Consultation on the Reorganization Plan of the Korea Disease Control and Prevention Agency to Strengthen Infectious Disease Response Capabilities' at the National Assembly Members' Office Building and made this decision.

Cho Jung-sik, the Policy Committee Chair of the Democratic Party, stated at a briefing, "The Korea Centers for Disease Control and Prevention, currently under the Ministry of Health and Welfare, will be newly established as the Korea Disease Control and Prevention Agency, an external agency at the vice-ministerial level, designated as the main agency for infectious disease disaster management with independent authority," adding, "The National Institute of Health will remain as an agency under the Korea Disease Control and Prevention Agency as it is, maximizing synergy in infectious disease response capabilities."

Chair Cho also added, "The Infectious Disease Research Center of the National Institute of Health will be expanded and reorganized into the National Infectious Disease Research Institute, creating a system where the Korea Disease Control and Prevention Agency can oversee the entire process from infectious disease surveillance to the development of therapeutics and vaccines, as well as support for commercialization in private facilities."

This content was produced with the assistance of AI translation services.